Cervomed Inc (CRVO) Directors and Executive Officers

Officers & Directors

Frank Zavrl
Director

Jane H. Hollingsworth, J.D.
Director

Jeff Poulton
Director

Robert J. Cobuzzi, Ph.D.
Chief Operating Officer and Director

John Alam, M.D.
President, Chief Executive Officer and Director

Sylvie Gregoire, PharmD.
Director

William Elder
General Counsel and Corporate Secretary

Marwan Sabbagh, M.D.
Director

Joshua S. Boger, Ph.D.
Chair of the Board ,

Cervomed Inc currently has 15 employees.

News about Cervomed Inc Key Personnel

CervoMed's Appointment of William Elder as CFO Bolsters Future Prospects for Neurologic Disorders Treatment

CervoMed s Strategic Appointment of William Elder as CFO Signals Promising Future for Neurologic Disorders Treatment
CervoMed Inc., a renowned clinical stage company dedicated to the development of treatments for age-related neurologic disorders, has recently announced a significant addition to its leadership team. William (Bill) Elder, currently serving as General Counsel and Corporate Secretary, will assume the role of Chief Financial Officer (CFO) effective June 1, 2024. This decision comes as a part of CervoMed s ongoing efforts to strengthen its financial management and drive further growth in the sector.
Elder s appointment as CFO is backed by his extensive experience in the field. Having serv...

CervoMed: Revolutionizing Healthcare with $149 Million in Major Funding

CervoMed Secures Major Funding with Leading Healthcare Investors

In a recent development, CervoMed, a prominent player in the healthcare sector, has announced its successful completion of a private placement financing round, raising $149.4 million. This impressive investment comes from a group of esteemed investors including RA Capital Management, Armistice Capital, Special Situations Funds, and Soleus Capital. The funding secured by CervoMed is expected to foster significant advancements in the company s innovative healthcare solutions and drive its market expansion.
Market Prospects and Investor Confidence:
This substantial private placement financing round indicates the promising growth ...